300676 华大基因
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.113-6.996-9.5050.9328.278
总资产报酬率 ROA (%)-0.082-5.077-6.9030.6645.606
投入资产回报率 ROIC (%)-0.097-6.092-8.1810.7766.451

边际利润分析
销售毛利率 (%)39.70937.59141.47249.90352.273
营业利润率 (%)-1.224-16.009-22.6223.46315.424
息税前利润/营业总收入 (%)-3.301-17.904-24.2171.60114.155
净利润/营业总收入 (%)-1.228-17.213-23.5872.15411.474

收益指标分析
经营活动净收益/利润总额(%)-174.25321.33644.178206.610115.020
价值变动净收益/利润总额(%)-25.457-0.2778.667-28.62638.560
营业外收支净额/利润总额(%)8.1571.5201.281-30.392-8.057

偿债能力分析
流动比率 (X)2.5962.4242.4192.4062.471
速动比率 (X)2.3882.2352.2082.2232.290
资产负债率 (%)24.73426.73826.07726.51128.945
带息债务/全部投入资本 (%)11.87212.22111.17514.78616.161
股东权益/带息债务 (%)729.323704.816787.159570.761508.284
股东权益/负债合计 (%)300.326270.386279.296273.186242.000
利息保障倍数 (X)1.67810.86018.603-1.518-118.561

营运能力分析
应收账款周转天数 (天)187.188161.248144.749151.33587.481
存货周转天数 (天)87.32084.20895.741109.04185.318